{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T18:14:10Z","timestamp":1788200050547,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T00:00:00Z","timestamp":1743984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Japanese Ministry of Health, Labour and Welfare","doi-asserted-by":"crossref","award":["H22-013"],"award-info":[{"award-number":["H22-013"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10096-025-05116-6","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T14:24:07Z","timestamp":1744381447000},"page":"1471-1480","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Additional biomarkers and emm types associated with group A streptococcal toxic shock syndrome: a Japanese nationwide observational study"],"prefix":"10.1007","volume":"44","author":[{"given":"Shigeo","family":"Hanada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeaki","family":"Wajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misako","family":"Takata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Morozumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Ubukata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,7]]},"reference":[{"key":"5116_CR1","doi-asserted-by":"publisher","DOI":"10.1128\/9781555819836","volume-title":"Gram-positive pathogens","author":"VA Fischetti","year":"2019","unstructured":"Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Braunstein M, Rood JI (2019) Gram-positive pathogens, 3rd edn. American Society for Microbiology, Washington, DC. DOI. https:\/\/doi.org\/10.1128\/9781555819836","edition":"3"},{"key":"5116_CR2","doi-asserted-by":"publisher","unstructured":"Frost HR, Davies MR, Velusamy S et al (2020) Updated emm-typing protocol for Streptococcus pyogenes. Clin Microbiol Infect 26:946e5\u2013946e8. https:\/\/doi.org\/10.1016\/j.cmi.2019.11.020","DOI":"10.1016\/j.cmi.2019.11.020"},{"key":"5116_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM198907063210101","volume":"321","author":"DL Stevens","year":"1989","unstructured":"Stevens DL, Tanner MH, Winship J et al (1989) Severe group A Streptococcal infections associated with a toxic shock-like syndrome and Scarlet fever toxin A. N Engl J Med 321:1\u20137. https:\/\/doi.org\/10.1056\/NEJM198907063210101","journal-title":"N Engl J Med"},{"key":"5116_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/clind\/16.6.792","volume":"16","author":"B Demers","year":"1993","unstructured":"Demers B, Simor AE, Vellend H et al (1993) Severe invasive group A Streptococcal infections in Ontario, Canada: 1987\u20131991. Clin Infect Dis 16:792\u2013800. https:\/\/doi.org\/10.1093\/clind\/16.6.792","journal-title":"Clin Infect Dis"},{"key":"5116_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.micinf.2004.06.006","volume":"6","author":"T Hasegawa","year":"2004","unstructured":"Hasegawa T, Hashikawa SN, Nakamura T, Torii K, Ohta M (2004) Factors determining prognosis in Streptococcal toxic shock-like syndrome: results of a nationwide investigation in Japan. Microbes Infect 6:1073\u20131077. https:\/\/doi.org\/10.1016\/j.micinf.2004.06.006","journal-title":"Microbes Infect"},{"key":"5116_CR6","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1128\/JCM.43.6.3101-3109.2005","volume":"43","author":"K Ekelund","year":"2005","unstructured":"Ekelund K, Darenberg J, Norrby-Teglund A et al (2005) Variations in Emm type among group A Streptococcal isolates causing invasive or noninvasive infections in a nationwide study. J Clin Microbiol 43:3101\u20133109. https:\/\/doi.org\/10.1128\/JCM.43.6.3101-3109.2005","journal-title":"J Clin Microbiol"},{"key":"5116_CR7","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1086\/520982","volume":"45","author":"J Darenberg","year":"2007","unstructured":"Darenberg J, Luca-Harari B, Jasir A et al (2007) Molecular and clinical characteristics of invasive group A Streptococcal infection in Sweden. Clin Infect Dis 45:450\u2013458. https:\/\/doi.org\/10.1086\/520982","journal-title":"Clin Infect Dis"},{"key":"5116_CR8","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1093\/cid\/ciw248","volume":"63","author":"GE Nelson","year":"2016","unstructured":"Nelson GE, Pondo T, Toews KA et al (2016) Epidemiology of invasive group A Streptococcal infections in the united States, 2005\u20132012. Clin Infect Dis 63:478\u2013486. https:\/\/doi.org\/10.1093\/cid\/ciw248","journal-title":"Clin Infect Dis"},{"key":"5116_CR9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM198707163170304","volume":"317","author":"LA Cone","year":"1987","unstructured":"Cone LA, Woodard DR, Schlievert PM, Tomory GS (1987) Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N Engl J Med 317:146\u2013149. https:\/\/doi.org\/10.1056\/NEJM198707163170304","journal-title":"N Engl J Med"},{"key":"5116_CR10","unstructured":"National Institute of Infectious Diseases Risk Assessment for Streptococcal Toxic Shock Syndrome (STSS) in Japan. https:\/\/www.niid.go.jp\/niid\/en\/2013-03-15-04-55-59\/2656-disease-based\/sa\/sfts\/cepr\/12608-stss-2023-2024eng.html. Accessed 21 December 2024"},{"key":"5116_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/S1473-3099(23)00112-6","volume":"23","author":"S Bagcchi","year":"2023","unstructured":"Bagcchi S (2023) Surge of invasive group A Streptococcus disease. Lancet Infect Dis 23:284. https:\/\/doi.org\/10.1016\/S1473-3099(23)00112-6","journal-title":"Lancet Infect Dis"},{"key":"5116_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1046\/j.1469-0691.2002.00398.x","volume":"8","author":"DL Stevens","year":"2002","unstructured":"Stevens DL (2002) Streptococcal toxic shock syndrome. Clin Microbiol Infect 8:133\u2013136. https:\/\/doi.org\/10.1046\/j.1469-0691.2002.00398.x","journal-title":"Clin Microbiol Infect"},{"key":"5116_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1473-3099(09)70066-0","volume":"9","author":"E Lappin","year":"2009","unstructured":"Lappin E, Ferguson AJ (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9:281\u2013290. https:\/\/doi.org\/10.1016\/S1473-3099(09)70066-0","journal-title":"Lancet Infect Dis"},{"key":"5116_CR14","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.jemermed.2018.01.020","volume":"54","author":"M Gottlieb","year":"2018","unstructured":"Gottlieb M, Long B, Koyfman A (2018) The evaluation and management of toxic shock syndrome in the emergency department: A review of the literature. J Emerg Med 54:807\u2013814. https:\/\/doi.org\/10.1016\/j.jemermed.2018.01.020","journal-title":"J Emerg Med"},{"key":"5116_CR15","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/antibiotics13010096","volume":"13","author":"E Atchade","year":"2024","unstructured":"Atchade E, De Tymowski CD, Grall N, Tanaka S, Montravers P (2024) Toxic shock syndrome: A literature review. Antibiot (Basel) 13:96. https:\/\/doi.org\/10.3390\/antibiotics13010096","journal-title":"Antibiot (Basel)"},{"key":"5116_CR16","doi-asserted-by":"publisher","first-page":"e154","DOI":"10.3346\/jkms.2024.39.e154","volume":"39","author":"TH Kim","year":"2024","unstructured":"Kim TH (2024) Toxic shock syndrome (TSS) caused by group A Streptococcus: novel insights within the context of a familiar clinical syndrome. J Korean Med Sci 39:e154. https:\/\/doi.org\/10.3346\/jkms.2024.39.e154","journal-title":"J Korean Med Sci"},{"key":"5116_CR17","unstructured":"Centers for Disease Control and Prevention (2025) https:\/\/www.cdc.gov\/group-a-strep\/about\/streptococcal-toxic-shock-syndrome.html. Accessed 8th February"},{"key":"5116_CR18","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.1993.03500030088036","volume":"269","author":"RF Breiman","year":"1993","unstructured":"Breiman RF, Davis JP, Facklam RR et al (1993) Defining the group A Streptococcal toxic shock syndrome: rationale and consensus definition. JAMA 269:390\u2013391. https:\/\/doi.org\/10.1001\/jama.1993.03500030088036","journal-title":"JAMA"},{"key":"5116_CR19","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1128\/JCM.44.4.1440-1446.2006","volume":"44","author":"M Morozumi","year":"2006","unstructured":"Morozumi M, Nakayama E, Iwata S et al (2006) Simultaneous detection of pathogens in clinical samples from patients with community-acquired pneumonia by real-time PCR with pathogen-specific molecular beacon probes. J Clin Microbiol 44:1440\u20131446. https:\/\/doi.org\/10.1128\/JCM.44.4.1440-1446.2006","journal-title":"J Clin Microbiol"},{"key":"5116_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/S0002-9343(97)00078-9","volume":"103","author":"R Kaul","year":"1997","unstructured":"Kaul R, McGeer A, Low DE, Green K, Schwartz B (1997) Population-based surveillance for group A Streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario group A Streptococcal study. Am J Med 103:18\u201324. https:\/\/doi.org\/10.1016\/S0002-9343(97)00078-9","journal-title":"Am J Med"},{"key":"5116_CR21","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00134-021-06506-y","volume":"47","author":"L Evans","year":"2021","unstructured":"Evans L, Rhodes A, Alhazzani W et al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med 47:1181\u20131247. https:\/\/doi.org\/10.1007\/s00134-021-06506-y","journal-title":"Intensive Care Med"},{"key":"5116_CR22","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/01.CCM.0000129486.35458.7D","volume":"32","author":"CH Wong","year":"2004","unstructured":"Wong CH, Khin LW, Heng KS, Tan KC, Low CO (2004) The LRINEC (Laboratory risk indicator for necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 32:1535\u20131541. https:\/\/doi.org\/10.1097\/01.CCM.0000129486.35458.7D","journal-title":"Crit Care Med"},{"key":"5116_CR23","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1469-0691.2009.03062.x","volume":"16","author":"T Takahashi","year":"2010","unstructured":"Takahashi T, Sunaoshi K, Sunakawa K et al (2010) Clinical aspects of invasive infections with Streptococcus dysgalactiae Ssp. Equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections. Clin Microbiol Infect 16:1097\u20131103. https:\/\/doi.org\/10.1111\/j.1469-0691.2009.03062.x","journal-title":"Clin Microbiol Infect"},{"key":"5116_CR24","doi-asserted-by":"publisher","first-page":"106954","DOI":"10.1016\/j.ijid.2023.12.002","volume":"142","author":"T Ikebe","year":"2024","unstructured":"Ikebe T, Okuno R, Uchitani Y et al (2024) Epidemiological shifts in and impact of COVID-19 on Streptococcal toxic shock syndrome in Japan: A genotypic analysis of group A Streptococcus isolates. Int J Infect Dis 142:106954. https:\/\/doi.org\/10.1016\/j.ijid.2023.12.002","journal-title":"Int J Infect Dis"},{"key":"5116_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1469-0691.2011.03624.x","volume":"18","author":"C Plainvert","year":"2012","unstructured":"Plainvert C, Doloy A, Loubinoux J et al (2012) Invasive group A Streptococcal infections in adults, France (2006\u20132010). Clin Microbiol Infect 18:702\u2013710. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03624.x","journal-title":"Clin Microbiol Infect"},{"key":"5116_CR26","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.37349\/emed.2023.00069","volume":"4","author":"K Zaman","year":"2023","unstructured":"Zaman K, Siddiq A, Mohanty A et al (2023) Group A Streptococcal infection in the united Kingdom: an emerging threat. Explor Med 4:1026\u20131032. https:\/\/doi.org\/10.37349\/emed.2023.00069","journal-title":"Explor Med"},{"key":"5116_CR27","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3201\/eid2905.221887","volume":"29","author":"X Zhi","year":"2023","unstructured":"Zhi X, Li HK, Li H et al (2023) Emerging invasive group A Streptococcus M1UK lineage detected by allele-specific PCR, England, 20201. Emerg Infect Dis 29:1007\u20131010. https:\/\/doi.org\/10.3201\/eid2905.221887","journal-title":"Emerg Infect Dis"},{"key":"5116_CR28","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3201\/eid2911.230856","volume":"29","author":"Y Li","year":"2023","unstructured":"Li Y, Rivers J, Mathis S et al (2023) Expansion of invasive group A Streptococcus M1UK lineage in active bacterial core surveillance, united States, 2019\u20132021. Emerg Infect Dis 29:2116\u20132120. https:\/\/doi.org\/10.3201\/eid2911.230856","journal-title":"Emerg Infect Dis"},{"key":"5116_CR29","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3201\/eid3011.241068","volume":"30","author":"AR Golden","year":"2024","unstructured":"Golden AR, Griffith A, Tyrrell GJ et al (2024) Invasive group A Streptococcus hypervirulent M1UK clone, Canada, 2018\u20132023. Emerg Infect Dis 30:2409\u20132413. https:\/\/doi.org\/10.3201\/eid3011.241068","journal-title":"Emerg Infect Dis"},{"key":"5116_CR30","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/scientificamerican0591-58","volume":"264","author":"VA Fischetti","year":"1991","unstructured":"Fischetti VA (1991) Streptococcal M protein. Sci Am 264:58\u201365. https:\/\/doi.org\/10.1038\/scientificamerican0591-58","journal-title":"Sci Am"},{"key":"5116_CR31","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1074\/jbc.271.3.1081","volume":"271","author":"P Akesson","year":"1996","unstructured":"Akesson P, Sj\u00f6holm AG, Bj\u00f6rck L (1996) Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J Biol Chem 271:1081\u20131088. https:\/\/doi.org\/10.1074\/jbc.271.3.1081","journal-title":"J Biol Chem"},{"key":"5116_CR32","doi-asserted-by":"publisher","unstructured":"Egesten A, Eliasson M, Johansson HM et al (2007) The CXC chemokine MIG\/CXCL9 is important in innate immunity against Streptococcus pyogenes. J Infect Dis 2007;195:684\u2013693. https:\/\/doi.org\/10.1086\/511824","DOI":"10.1086\/511824"},{"key":"5116_CR33","doi-asserted-by":"publisher","first-page":"102339","DOI":"10.1016\/j.isci.2021.102339","volume":"24","author":"A Neumann","year":"2021","unstructured":"Neumann A, Happonen L, Karlsson C et al (2021) Streptococcal protein SIC activates monocytes and induces inflammation. iScience 24:102339. https:\/\/doi.org\/10.1016\/j.isci.2021.102339","journal-title":"iScience"},{"key":"5116_CR34","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/cid\/ciy401","volume":"67","author":"T Parks","year":"2018","unstructured":"Parks T, Wilson C, Curtis N, Norrby-Teglund A, Sriskandan S (2018) Polyspecific intravenous Immunoglobulin in clindamycin-treated patients with Streptococcal toxic shock syndrome: a systematic review and meta-analysis. Clin Infect Dis 67:1434\u20131436. https:\/\/doi.org\/10.1093\/cid\/ciy401","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05116-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-025-05116-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-025-05116-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T12:57:16Z","timestamp":1748350636000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-025-05116-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,7]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5116"],"URL":"https:\/\/doi.org\/10.1007\/s10096-025-05116-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,7]]},"assertion":[{"value":"10 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and Guidelines for Epidemiologic Studies issued by the Japanese Ministry of Health, Labor, and Welfare. The study protocol was approved by the Institutional Review Board of the Keio University School of Medicine Ethics Committee (approval number: 20130455).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The need for written informed consent was waived owing to the use of anonymized stored samples and data. Patient medical records in the database were obtained anonymously using a survey form completed by the attending physicians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The following authors received financial support within the last 3 years: K. U. from Pfizer Japan Inc., HORIBA, Ltd., and Abbott Diagnostics Medical Co., Ltd., J. S. from Roche Diagnostics K.K., Sysmex Corporation, Asahi Kasei Pharma Corporation, Shionogi & Co., Ltd., and Pfizer Japan Inc. All other authors declare that they have no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}